Cannara Biotech Inc. (LOVE:TSX)
Cannara has maintained a solid growth trajectory, with expectations of ~20% going forward through its measured expansion plan.
The Company has best-in-class profitability with adjusted EBITDA margins of 30%, benefiting from its footprint in Quebec.
The launch of vape products in Quebec will serve as a growth driver for the Quebec segment, while distribution expands in the other provinces.
Investment Summary
Cannara is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,600,000 SF, providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price.
Company Description
Research
